Best HealthTech Companies in Lausanne, Switzerland
The 58 best HealthTech companies in Lausanne, Switzerland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: MindMaze Therapeutics.
Our analysis of 864 HealthTech companies
$73.2b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best HealthTech companies in Lausanne
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MindMaze Therapeutics Developer of neurotherapeutic solutions combining behavior, software, devices, and data | $361M | 1 mo ago | Public | — | 2012 | Tej Tadi Founder & Co-CEO | — | — |
| 2 | MindMaze 🦄 Digital neurotherapeutic platform for digital assessments and therapeutics | $224M | 52 mo ago | Series B | 75 | 2012 | Tej Tadi Founder & CEO | 36 patents AI-driven neurorehabilitation devices for hand therapy, facial expression analysis, and SLAM tracking | 1 job opening · 3 partnerships · 2 expansions |
| 3 | Aleva Neuro Develops implantable deep brain stimulation systems that enables therapies for neurological diseases | $57M | 54 mo ago | Series E | 30 | 2008 | Claudio Pollo Co-Founder | — | — |
| 4 | Vandria Developer of in-vitro screening platform for drug discovery and development | $31M | 22 mo ago | Series A | 6 | 2018 | Patrick Aebischer Co-Founder | 38 patents Neuroprotective small‑molecule therapeutics using urolithin derivatives for ALS treatment | — |
| 5 | GenomSys Provider of solutions and systems for efficient genomic information processing | $9M | 81 mo ago | Series A | 20 | 2015 | — | 199 patents Efficient compression, storage, indexing, and retrieval of large genomic sequence data. | 1 partnership |
| 6 | Glia Pharm Developer of treatments for neurological and psychiatric disorders | $6M | 30 mo ago | Series A | 9 | 2016 | — | — | — |
| 7 | PIQ Multisport Sensor | $6M | 133 mo ago | Deadpooled | 8 | 2009 | — | — | — |
| 8 | Atinary AI-based R&D operation automation platform for science labs | $5M | 33 mo ago | Seed | 10 | 2020 | Hermann Tribukait Co-Founder & CEO | — | 1 expansion · 1 award |
| 9 | Xsensio Provider of wearable biosensors 37Talent top 34%Funding top 37%Product top 41%Moat top 42% All 10 signals ▾Talenttop 34% Fundingtop 37% Producttop 41% Moattop 42% Growthtop 45% Innovationtop 46% Patentstop 50% Globalbottom 39% Techbottom 36% Marketbottom 28% Talent: Analyst team rating 4/5 · 2 named leaders on record Funding: Raised $4.6M across 9 rounds · 9 rounds over 12 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 37/100 | $5M | 4 mo ago | Series A | 16 | 2014 | Karin Jaymes Co-Founder | 19 patents Patents concentrated in health & consumer products | — |
| 10 | Biospectal App based optical analysis platform for blood pressure monitoring | $4M | 59 mo ago | Seed | 17 | 2017 | Eliott Jones Chief Executive Officer | 15 patents Non‑invasive blood pressure estimation via photoplethysmography and optical signal analysis | — |
| 11 | Aesyra A wearable solution for managing bruxism | $3M | 31 mo ago | Seed | 4 | 2017 | Marco Letizia Co-Founder & CEO | 14 patents Sensorized oral appliances for bruxism and sleep‑apnea monitoring and treatment | — |
| 12 | Isospec Analytics Provider of drug and biomarker discovery for pharmaceutical companies | $2M | 26 mo ago | Seed | — | 2022 | Ahmed Faleh CEO | — | 1 award |
| 13 | Biped AI-based driving assistant for blind people | $2M | 36 mo ago | Seed | 6 | 2021 | Marco Trujillo Co-Founder & COO | — | — |
| 14 | autonomyo Provider of mobility device for disabled person 8Talent top 38%Funding bottom 42%Global bottom 36%Market bottom 14% All 4 signals ▾Talenttop 38% Fundingbottom 42% Globalbottom 36% Marketbottom 14% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $1.6M across 1 rounds · 1 rounds over 5 yrs (0.2/yr) rank vs industry peers · Fliar Intelligence Index 8/100 | $2M | 8 mo ago | Seed | 8 | 2020 | Amalric Ortlieb CTO and co-founder | — | — |
| 15 | Saphetor Developer of platform for automated next-gen sequencing analysis | $1M | 124 mo ago | Seed | 70 | 2014 | — | — | — |
| 16 | ChemAlive Cloud-based computational platform for chemical research | $808K | 102 mo ago | Funding Raised | 2 | 2014 | — | — | — |
| 17 | Twiice Developer of exoskeleton for people suffering from mobility issues | $577K | 21 mo ago | Seed | 9 | 2016 | Tristan Vouga Co-Founder | — | — |
| 18 | Pryv PRYV offers e-health data middleware. | $428K | 101 mo ago | Seed | 20 | 2012 | Simon Goumaz Co-founder | — | — |
| 19 | Insiders Provider of tech-hardware for multiple sports performance analytics | $355K | 95 mo ago | Seed | 10 | 2012 | Julie Coutts CEO | — | — |
| 20 | Sensemodi Wearable device for joint health assessment | $164K | 53 mo ago | Seed | 6 | 2009 | David Atienza Co-Founder | — | — |
| 21 | Emovo Care Developer of products intended to improve movement and rehabilitation outcomes | $154K | 33 mo ago | Seed | 5 | 2018 | Luca Randazzo Co-Founder & CEO | — | — |
| 22 | Rea Diagnostics Provider of a wearable diagnostic device to monitor the risk of preterm birth | $115K | 29 mo ago | Funding Raised | 6 | 2020 | Loulia Kassem Co-Founder & CEO | — | — |
| 23 | Juvion Health Sciences Provider of therapeutics to prevent neuron muscle communication | $110K | 17 mo ago | Funding Raised | — | 2024 | Jamshid Asadzadeh Co-Founder & CSO | — | — |
Top 12 HealthTech companies in Lausanne
#1
Public · Lausanne, Vaud · founded 2012$360.6Mraised▾
Developer of neurotherapeutic solutions combining behavior, software, devices, and data. The company offers a platform for brain health and recovery. It provides precision neurotherapeutics through a portfolio of solutions. The company also develops formulations for rare diseases. Its offerings include an immersive experience platform for brain recovery and a neurorehabilitation system. It provides a hand training peripheral and technology for digital motion assessments.
- Feb 2022Series B$105M
- Feb 2022Grant (prize money)$12.1M
- Oct 2021Conventional Debt$125M
- Sep 2017Angel—
#2
Series A · Lausanne, Vaud · founded 2014 · 16 employees$4.6Mraised▾
Provider of wearable biosensors. It manufactures intelligent and connected biosensors based on nanotechnology which collect biochemical information from the surface of the skin of the user by analyzing electrolytes, metabolites, small molecules, and proteins. It also offers a companion mobile app that allows users to monitor parameters and customize sensors.
- Mar 2026Series A$7M
- Feb 2023Series A—
- Sep 2022Grant (prize money)$48.7K
- Dec 2021Series A$4.6M
#3
Seed · Lausanne, Vaud · founded 2020 · 8 employees$1.6Mraised▾
Autonomyo provides mobility devices for disabled persons. It helps people with neurological gait disorders to walk again. The lower limb exoskeleton enables people with muscular and neurological deficiencies to walk.
- Nov 2025Seed$1.6M
- Dec 2021Conventional Debt—
#4
Series A · Lausanne, Vaud · founded 2018 · 6 employees$30.7Mraised▾
Developer of in-vitro screening platform for drug discovery and development. The company has created a platform for identifying and discovering small compounds (mitophagy inducers). It aids in the identification of the leading candidate molecule linked to age-related and chronic diseases.
- Aug 2024Series A—
- Dec 2023Series A$20.6M
#5
MindMaze 🦄Series B · Lausanne, Vaud · founded 2012 · 75 employees$223.5Mraised▾
Developer of digital neurotherapeutics (DTx) devices designed to accelerate the brain's ability to recover, learn and adapt. The company utilizes immersive virtual reality, motion capture and neurophysiological recording technologies to build novel interfaces for neurorehabilitation, game training and three-dimensional imaging in real-time, enabling patients to restore motor function after stroke or brain trauma.
#6
Series E · Lausanne, Vaud · founded 2008 · 30 employees$57Mraised▾
Aleva Neurotherapeutics has developed a MEMS technology backed neurostimulation platform, which is based on micro deep brain stimulation technology that enables therapies for neurological diseases. They are primarily targeting indications such as parkinsonʼs disease and Essential Tremor. They have developed directSTIM™ DBS (Deep Brain Stimulation) System - an implantable deep brain stimulation systems; spiderSTIM™ DBS Diagnostic System.
- Dec 2021Series E—
- Dec 2019Series E$8M
- Oct 2017Series D$13M
- May 2016Series C$18M
#7
Series A · Lausanne, Vaud · founded 2016 · 9 employees$6.4Mraised▾
Developer of treatments for neurological and psychiatric disorders. The company seeks to develop neuroactive agents that target Glial Cells and Astrocytes with treatment potential in a variety of pathologies, including cognitive impairments of various origins, neurodegenerative diseases, multiple sclerosis, epilepsy, depression, and migraine.
- Dec 2023Series A$4.2M
- Jul 2022Seed$102K
- May 2020Seed$2.1M
- Oct 2017Grant (prize money)—
#8
Seed · Lausanne, Vaud · founded 2016 · 9 employees$576.9Kraised▾
Developer of exoskeleton for people suffering from mobility issues. The company offers TWIICE which allows people with spinal cord injury to stand up, walk and climb stairs. Also provides WIITE which allows paraplegics people to perform ski touring.
- Sep 2024Conventional Debt$471.8K
- Aug 2022Conventional Debt$105.1K
- Apr 2017Seed—
#9
Seed · Lausanne, Vaud · founded 2020 · 10 employees$5Mraised▾
AI-based R&D operation automation platform for science labs. It integrates AI, machine learning, and automation into a single closed-loop to enable and accelerate the digital transformation of Industry 4.0. It offers AtinaryTM Nexus for the academic community to connect research groups and facilitate scientific collaborations all across the globe, AtinaryTM SDLabs Scientia is an open-platform product for the academic community to promote science, academic research, and knowledge, and AtinaryTM SDLabs Enterprise is a software suite for companies to accelerate process optimization and materials discovery using AI and machine learning.
- Sep 2023Seed$5M
- Mar 2022Seed—
#10
Seed · Lausanne, Vaud · founded 2022$1.9Mraised▾
Provider of drug and biomarker discovery for pharmaceutical companies. The company has proprietary fingerprinting technology that provides key information during target validation and compound screening for optimal decision-making and development allowing pharmaceutical companies to speed up the drug discovery and development phases by offering a faster and more reliable approach to biomolecular analysis.
- Apr 2024Seed$1.9M
- Sep 2022Grant (prize money)$40.4K
#11
Seed · Lausanne, Vaud · founded 2017 · 4 employees$3Mraised▾
A wearable solution for managing bruxism. The company develops intraoral sensors that help dental professionals in reducing damages induced on dental prostheses by occlusal problems. It is a wearable solution that will help clinicians in managing bruxism diagnosis, monitoring, and therapy.
- Dec 2023Seed$3M
- Jun 2019Seed—
- 2017Seed$10.2K
#12
Funding Raised · Lausanne, Vaud · founded 2024$110.1Kraised▾
Provider of therapeutics to prevent neuron muscle communication. It developing solutions to enhance health span and mobility in the elderly. It utilize an AI driven discovery platform for compound screening and integrate non invasive neuromuscular monitoring technology for real time tracking of brain to muscle communication.
- Jan 2025Conventional Debt$110.1K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of HealthTech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Digital Health in Lausanne is moving
A read on the academic research around Digital Health in Lausanne — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 59 papers.
University of Lausanne and EPFL lead Lausanne's digital-health research, focusing predominantly on chronic disease management and mHealth, with a cautiously contested tone (mean stance 0.21, concerns outpacing breakthroughs).
- University of Lausanne32
- Centre universitaire de médecine générale et santé publique, Lausanne19
- École Polytechnique Fédérale de Lausanne11
- University Hospital of Lausanne9
- Business School Lausanne1
- Wearable computer4
- Clinical decision support system2
- Suite2
- Workflow2
- Decision support system2
- Public health1→4
- Health informatics1→3
- Health administration2→3
- Nursing research1→6
- Health care1→6
- Health administration2→6
- Health informatics1→4
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.